Notes
2010 euros
Reference
Mlcoch T, et al. Cost-of-illness analysis and regression modeling in cystic fibrosis: a retrospective prevalence-based study. European Journal of Health Economics : 7 Jan 2016. Available from: URL: http://dx.doi.org/10.1007/s10198-015-0759-9
Rights and permissions
About this article
Cite this article
FEV1 is indicator of economic impact of cystic fibrosis. PharmacoEcon Outcomes News 745, 16 (2016). https://doi.org/10.1007/s40274-016-2757-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-016-2757-2